2022

Amesh Adalja, MD, discusses rapid and PCR testing amid the holidays in the United States.
 

Amesh Adalja, MD, discusses what we do and don't know about the Omicron variant as we head into the holiday season. 

Keri Althoff, associate professor of Epidemiology, discusses the surge in Omicron cases across the globe and how it may affect people's holiday travel plans. 

Amesh Adalja, MD, discusses the Omicron variant and the possibility of it becoming the dominant variant in the U.S., emphasizing the importance of more Americans getting vaccinated. 

Keri Althoff, associate professor of Epidemiology, discusses the uptick in cases in various states as the holiday season approaches. She discusses the spread of the Delta variant and preventing future spread of Omicron. 

Keri Althoff, associate professor of Epidemiology, discusses next steps in the pandemic as the Omicron variant continues to spread in the United States. 

Amesh Adalja, MD, discusses the new travel restrictions in place in wake of the Omicron variant. 

Amesh Adalja, MD, discusses the uptick in COVID cases in certain state ahead of gatherings for the Thanksgiving holidays. 
 

Keri Althoff, associate professor of Epidemiology, discusses the uptick and surge in COVID cases in various U.S. states ahead of the holidays. 

Amesh Adalja, MD, discusses the new COVID therapies and their impacts on stemming the pandemic. 

Keri Althoff, associate professor of Epidemiology, discusses the recent surge in COVID cases in various states. 
 

Keri Althoff, associate professor of Epidemiology, discusses the COVID antiviral therapeutic pills from Pfizer and Merck. 

Amesh Adalja, MD, discusses the CDC's recent approval of Pfizer's vaccine for children ages 5–11 and how it will impact the pandemic's trajectory. 

Keri Althoff, associate professor of Epidemiology, discusses spread of the virus, as well as travel concerns amid the pandemic and the upcoming holiday season. 

Amesh Adalja, MD, discusses the FDA advisory panel's decision to approve Pfizer's COVID vaccine for children 5-11 years of age. 

Amesh Adalja, MD, discusses the situation in the Europe and whether the U.S. is headed in the same direction. 

Keri Althoff, associate professor of Epidemiology, discusses FDA Advisory Committee's recent vote to approve Moderna's  booster and Pfizer's additional shot. 

Amesh Adalja, MD, discusses the importance of getting more people vaccinated, as well as COVID-19 booster shots after Moderna and J&J suggest they would be beneficial. 

Keri Althoff, associate professor of epidemiology, discusses national COVID trends and what to expect in the coming weeks/months as far as another surge of cases.

Keri Althoff, associate professor of epidemiology discusses the recent announcement from Merck's antiviral COVID-19 pill.

Keri Althoff, associate professor of epidemiology, discusses the recent ACIP decision on COVID boosters for certain populations in the U.S.

Amesh Adalja, MD, discusses COVID booster shots and their potential impact, emphasizing the importance of getting more people vaccinated.

Amesh Adalja, MD, discusses President Biden's recent vaccine mandate for employers with more than 100 employees.

Keri Althoff, associate professor of epidemiology, discusses President Biden's recent COVID-19 action plan.

Amesh Adalja, senior scholar at the Johns Hopkins Center for Health Security, discusses how COVID will continue to be with us over the years as an endemic, rather than a pandemic.  

Amber D'Souza, epidemiologist, discusses the pros and cons of vaccine mandates and incentive programs in the workplace in the U.S.

Amesh Adalja, MD, discusses COVID vaccine efficacy and potential booster shots for the J&J vaccine.

Keri Althoff, associate professor of epidemiology, discusses the Biden Administration's plan to allow Americans to get a COVID booster shot eight months after vaccination while other countries vaccination rates remain low due to lack of access.

Amesh Adalja, MD, discusses the Biden's Administration's recent announcement on COVID-19 booster shot recommendations.

Keri Althoff, Associate Professor of Epidemiology, discusses the recent surge in COVID-19 vaccination rates in various parts of the United States.

David Dowdy, an epidemiologist, discusses what we do and don't know about Long COVID, its symptoms and its implications.

Keri Althoff, associate professor of Epidemiology, discusses the future of travel during the pandemic as cases begin to surge again and the delta variant continues to spread.

Gigi Gronvall, senior scholar at the Center for Health Security, discusses priorities and considerations as we look to safely return children to the classroom during the pandemic.

Gigi Gronvall, a senior scholar at the Center for Health Security, discusses a recent study linking excess COVID cases and deaths to lifted eviction moratoriums.

Amesh Adalja discusses the recent shift in CDC masking recommendations and the pandemic among the unvaccinated.

Amesh Adalja, MD, discusses virus sequencing and the role it plays in identifying viruses and tracking mutations.

Keri Althoff, Associate Professor of Epidemiology, discusses how epidemiologists are looking at the next potential pandemic.

Keri Althoff, Associate Professor of Epidemiology, discusses Pfizer's recent announcement about the potential need for a third booster dose.

Amesh Adalja, MD, discusses the vaccination rates in the U.S. after President Biden announced the country missed his goal of achieving 70% of the Americans receiving at least one COVID-19 shot by Fourth of July.

Keri Althoff, Associate Professor of Epidemiology, discusses President Biden's response team efforts to fight the delta variant and increase vaccination coverage in pockets of the U.S.

Amesh Adalja, MD, discusses recent studies on the effectiveness of mixing vaccines against the growing delta variant.

Keri Althoff, Associate Professor of Epidemiology, discusses the theory behind Covid's origin and what scientists are looking at to ensure we're better prepared and have additional protections so that something like this doesn't happen again.

Amesh Adalja, MD, discusses the transmissibility and spread of the delta variant.

Keri Althoff, Associate Professor of Epidemiology, discusses the U.S. investment in developing antiviral medicines for COVID and other viruses with pandemic potential (edited)

Amesh Adalja, MD, discusses the projected timeline for COVID boosters, examining the factors that we need to measure in order to determine when/if they're needed.

Keri Althoff, Associate Professor of Epidemiology, discusses recent research finding that mixing COVID shots could boost overall immunity against the virus.

Amesh Adalja, MD, discusses President Biden's forthcoming world vaccination strategy, as well as vaccinating younger children.

Keri Althoff, Associate Professor of Epidemiology, discusses the recent U.S. vaccine donations to countries in need of doses, explaining many countries do not have access to vaccines at anywhere nearly the level that the U.S. does.

Amesh Adalja, MD, discusses the milestone of zero deaths from COVID-19 in the UK and NYC for the first time in the pandemic, attributing the victory to the efficacy of the COVID vaccines.

Keri Althoff, Associate Professor of Epidemiology, discusses the decline in COVID cases in the U.S. and potential expectations of a surge after the Memorial Day holiday.

Amesh Adalja, MD, discusses his thoughts on the Olympics and whether or not they should go forward in Japan.

Keri Althoff, Associate Professor of Epidemiology, discusses the progress of the United States' vaccination campaign, as well as the status of the COVID surge in India and variants popping up across the globe.

Amesh Adalja, MD, discusses the return to "normal" life in the United States as more people get vaccinated, going over the new public health guidelines.

Keri Althoff, Associate Professor of Epidemiology, discusses the CDC's new guidance for vaccinated individuals stating that they do not need to wear masks or physically distance indoors, outside, or in large gatherings.

Amesh Adalja, MD, discusses the situation in India and what it could mean for the future of the pandemic on a global scale.

Keri Althoff, Associate Professor of Epidemiology, discusses the dire situation in India and how the U.S. can support the country.

Amesh Adalja, MD, discusses the U.S. decision to begin shipping vaccines to countries such as India and Brazil facing tremendous COVID-19 hotspots.

Keri Althoff, Associate Professor of Epidemiology, discusses the hotspots of cases around the country and around the world, specifically focusing on the situation in India and how it could play out.

Keri Althoff, Associate Professor of Epidemiology, discusses the vaccine gap in minority communities and what states can do to bridge it.

Amesh Adalja, MD, discusses President Biden's efforts to ramp up vaccinations nationwide, as well as vaccine hesitancy in the U.S.

Keri Althoff, Associate Professor of Epidemiology, discusses the effects of the recent J&J pause on vaccine hesitancy and rollout in the U.S.

Amesh Adalja, MD, discusses the recent pause on the J&J vaccine rollout in the U.S. as the CDC meets to discuss the data on shot and how to move forward.

Keri Althoff, Associate Professor of Epidemiology, discusses how the pandemic will continue evolve, referencing public health and economic health, as wealthier nations have more access to COVID-19 vaccines compared to lower-and-middle income countries.

Amesh Adalja, MD, discusses the recent NFL announcement about bringing fans back into stadiums and the effect that, as well as mass gatherings, may have on COVID-19 cases in the U.S.

Amber D'Souza, Professor of Epidemiology, discusses the recent J&J manufacturing error, resulting in a setback in vaccine supply. She also explains why we're seeing a rise in cases, despite tremendous progress in vaccinations.

Amesh Adalja, MD, discusses new data from Pfizer indicating its COVID-19 vaccine is safe and effective in children ages 12-15 and the timeline for vaccinations going forward.

Keri Althoff, Associate Professor of Epidemiology, examines the factors behind the rising number of Covid-19 cases in the United States.

Amesh Adalja, MD, discusses the latest news pertaining to the AstraZeneca vaccine, which has faced criticism over providing outdate trial results in the U.S.

Keri Althoff, Associate Professor of Epidemiology, discusses the vaccine eligibility expansion in the U.S., emphasizing the importance of access for everyone, particularly for the communities hardest hit by the pandemic.

Keri Althoff, Associate Professor of Epidemiology, discusses one healthcare one year after COVID was first declared a pandemic, specifically addressing what we've learned and how we can move forward.

Amesh Adalja, MD, discusses the vaccine rollout in the U.S., specifically addressing the news out of Alaska. The state recently announced opening up vaccines to everyone in the state over the age of 16.

Keri Althoff, Associate Professor of Epidemiology, discusses the WHO investigation into the origins of the COVID virus and why it's important to understand where the virus came from.

Amesh Adalja, MD, discusses President Biden's new timetable for vaccinations and what summer may look like in the U.S., as well as Gov. Abbott's recent re-opening announcement for the state of Texas.

Keri Althoff, Associate Professor of Epidemiology, discusses the FDA's pending approval of the Johnson & Johnson COVID-19 one-shot vaccine and how it could bolster the United States' fight against the coronavirus.

Amesh Adalja, MD, discusses the efficacy of the J&J COVID vaccine and what it’s approval in the U.S. would mean for the country’s fight to stem the pandemic.

Keri Althoff, Associate Professor of Epidemiology, discusses how the U.S. recent weather crisis is delaying vaccinations across the country and how the COVID variants threaten the country's progress towards stemming the pandemic.

Amesh Adalja, MD, discusses the timeline for vaccine rollout in the U.S. after President Biden announced that he's invoked the National Defense Act, which allows the government to nationalize commercial production in emergencies and, in this case, ramp up vaccine shipments.

Keri Althoff, Associate Professor of Epidemiology, discusses the latest trends related to COVID-19 case numbers, as well as the new variants popping up across the country.

Amesh Adalja, MD, discusses the recent data released on Israel's COVID-19 deaths and how vaccination is bringing those rates down.

Keri Althoff, Associate Professor of Epidemiology, discusses the approval process and timeline for the new J&J COVID-19 vaccine.

Amesh Adalja, MD, discusses the new data released on the Astra vaccine, as well as how it compares to some of the other vaccines being developed against the virus such as Moderna, Pfizer, and BioNTech.

Keri Althoff, Associate Professor of Epidemiology, discusses Johnson & Johnson’s one-shot vaccine, which has generated strong protection against Covid-19 in a large, late-stage trial, raising hopes that it can rapidly reshape a stumbling immunization campaign.

Amesh Adalja, MD, discusses the Biden-Harris vaccine rollout and distribution plan and what to expect in the coming weeks and months as Americans look to get vaccinated.

Keri Althoff, Associate Professor of Epidemiology, discusses the U.K.’s new plans to control the spread of the new COVID variant, as well as President Biden’s 100 day plan to tackle the virus.

Amesh Adalja, MD, discusses President Joe Biden's plans to tackle the coronavirus and when the country may expect to see the effects of the president's actions.

Keri Althoff, Associate Professor of Epidemiology, discusses the latest surge of COVID-19 cases and how long we can expect to have public health safety measures in place.

Amesh Adalja, MD, discusses the U.S. COVID-19 death toll, as well as what to expect with vaccine distribution and the return to some semblance in the coming months.

Keri Althoff, Associate Professor of Epidemiology, discusses the latest surge of the coronavirus cases in the U.S. and how the country needs to prepare for the next few months ahead.

Amesh Adalja, MD, discusses vaccine urgency and timelines as cases rise globally and countries, including the U.S., face a new variant of the virus.